The National Cancer Institute is launching a major clinical trial in which it hopes to become a matchmaker between 1,000 advanced cancer patients and a growing new or existing drugs that target genetic mutations that are driving the growth of their tumors.
from WSJ.com: US Business http://ift.tt/1SRaPQf
via IFTTT
No comments:
Post a Comment